Laurence M. Corash - 01 Mar 2022 Form 4 Insider Report for CERUS CORP (CERS)

Role
Chief Scientific Officer
Signature
Laurence M. Corash by Chrystal Menard, attorney-in-fact
Issuer symbol
CERS
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 18:40:45 UTC
Previous filing
21 Dec 2021
Next filing
15 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERS Restricted Stock Unit Award $0 +45,000 +2.2% $0.000000 2,072,586 01 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERS Option (Right to Buy) Award +90,000 90,000 01 Mar 2022 Common Stock 90,000 $5.76 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
F2 One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter.
F3 Not applicable.